Humana Inc vs Vanguard Global ex-US Real Estate Index Fd ETF — how do they compare? Humana Inc trades at $437.2 (market cap $47.61B), while Vanguard Global ex-US Real Estate Index Fd ETF trades at $41.82 (market cap $3.80B). The key difference: Humana Inc is far larger — about 12.5× Vanguard Global ex-US Real Estate Index Fd ETF's market cap, and Humana Inc pays a 0.89% dividend while Vanguard Global ex-US Real Estate Index Fd ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and Vanguard Global ex-US Real Estate Index Fd ETF for 95 Days on average.
| HUM | VNQI | |
|---|---|---|
Market Cap | $47.61B | $3.80B |
Volume | 1,827,332 | 336,661 |
Sector | Health | — |
52-Week High | $409.85 | $50.76 |
52-Week Low | $163.67 | $41.81 |
Typical Hold Time | 53 Days | 95 Days |
Enterprise Value | $54.97B | — |
Dividend Yield | 0.89% | — |
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $387.12, down 4.24% today, but maintains a bullish technical outlook with strong institutional support. The stock shows mixed fundamentals with revenue growth to $129.66B in 2025 but declining profit margins at 0.88%. Recent analyst upgrades, including Barclays' $515 target on September 25, 2026, highlight optimism despite ongoing Medicare Advantage plan adjustments affecting member transitions.
Investment outlook remains cautiously optimistic with a consensus price target of $432.63 offering 12% upside. Risks include margin compression, regulatory scrutiny from Medicare billing practices, and competitive pressures in managed care. The company's strong cash position of $20.44B and consistent dividend payments provide stability amid enrollment volatility.
VNQI (Vanguard Global ex-U.S. Real Estate ETF) trades at $41.81, down 0.59% with bearish technical signals from moving averages. The ETF provides international real estate exposure across 30+ countries with a 0.12% expense ratio and competitive dividend yield. Recent news highlights declining short interest and comparisons with domestic real estate ETFs, while technical indicators show oversold RSI readings amid a bearish trend.
The outlook remains cautious given the bearish technical momentum and global real estate market headwinds. Investment opportunity lies in international diversification and higher yield, but risks include currency fluctuations and underperformance versus US real estate. Analyst sentiment is mixed with focus on expense ratios and geographic exposure differences.
Trailing returns across standard periods
Latest headlines on both assets
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →The fund employs an indexing investment approach designed to track the performance of the S&P Global ex-US Property Index, a float-adjusted, market-capitalization-weighted index that measures the equity market performance of international real estate stocks in both developed and emerging markets. The index is composed of stocks of publicly traded equity real estate investment trusts (known as REITs) and certain real estate management and development companies (REMDs).
Read more on VNQI →